SCHEMBL18291271

SCHEMBL18291271

Nc1ccc(CN2CCNCC2=O)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.41
CDK6 Q00534 1/20 0.41
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40
GABRG3 Q99928 1/20 0.40
GABRQ Q9UN88 1/20 0.40
CHRNA1 P02708 2/20 0.39
CHRNA3 P32297 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291305 0.83 CHRM1 (0.44) CDK4CDK6GABRA1GABRA5SMN1; SMN2
SCHEMBL20038452 0.83 CDK4 (0.41) CDK4CDK6CHRNA1CHRNA3CHRNA7
SCHEMBL18291704 0.81 ALDH1A1 (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20249148 0.80 CDK4 (0.40) CDK4CDK6CHRNA1CHRNA3CHRNA7
SCHEMBL20037443 0.80 CDK4 (0.50) CDK4CDK6ALDH1A1SMN1; SMN2CXCR4
SCHEMBL18291700 0.79 L3MBTL1 (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1653036 0.78 TEC (0.39) CXCR4
SCHEMBL3321207 0.77 CXCR4 (0.51) CXCR4
SCHEMBL29475479 0.77 CXCR4 (0.51) CXCR4
SCHEMBL18291695 0.77 SMN1; SMN2 (0.58) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed
WO-2016194831-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 帝人ファーマ株式会社 2016-12-08 WO disclosed